β-Apo-13-carotenone
Code | Size | Price |
---|
TAR-T13431-5mg | 5mg | £334.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T13431-10mg | 10mg | £516.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T13431-25mg | 25mg | £952.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T13431-50mg | 50mg | £1,505.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T13431-100mg | 100mg | £2,238.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
β-Apo-13-carotenone is a naturally occurring β-apocarotenoid, and is a RXRα antagonist.
CAS:
17974-57-1
Formula:
C18H26O
Molecular Weight:
258.405
Purity:
0.98
SMILES:
CC(=O)C=CC=C(/C)C=CC1=C(C)CCCC1(C)C
References
1. Eroglu A, et al. The eccentric cleavage product of ?-carotene, ?-apo-13-carotenone, functions as an antagonist of RXR?. Arch Biochem Biophys. 2010 Dec 1;504(1):11-6.
2. Sun J, et al. ?-Apo-13-carotenone regulates retinoid X receptor transcriptional activity through tetramerization of the receptor. J Biol Chem. 2014 Nov 28;289(48):33118-24.
3. Wang CX, et al. Actions of ?-apo-carotenoids in differentiating cells: differential effects in P19 cells and 3T3-L1 adipocytes. Arch Biochem Biophys. 2015 Apr 15;572:2-10.